Oncology

Latest News

Neoadjuvant radiotherapy was associated with longer time spent in the hospital and a higher risk of short- and long-term wound complications. | Image credit: cacaroot - stock.adobe.com
Radiotherapy Raises Risk of Complications After Limb STS Surgery

September 16th 2025

Patients who underwent neoadjuvant radiotherapy for soft tissue sarcoma (STS) spent longer in the hospital and were more likely to have wound complications.

AJMC Q&A with Danny Nguyen, MD | Background image credit: ipopba - stock.adobe.com
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD

September 15th 2025

The use of miRNA in situ hybridization shows clear subtype-specific miRNAs, which the authors said warrant further investigation. | Image credit: CrazyJuke - stock.adobe.com
miRNA Profiling May Unlock SCLC Biomarkers

September 13th 2025

Value-Based Care Veterans, Surprised by EOM Results, Ponder Next Move
Value-Based Care Veterans, Surprised by EOM Results, Ponder Next Move

September 11th 2025

FDA | Image credit: Postmodern Studio.jpeg
FDA Approves Selumetinib for Children With NF1 and Inoperable Tumors

September 10th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
September 17th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 17th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Cancer Does Not Stop for COVID-19, But Reform Becomes a Challenge
October 28th 2020

Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge

Rose McNulty
During a session on day 1 of the Community Oncology Alliance (COA) Virtual Payer Exchange Summit on Oncology Payment Reform, a panel of experts discussed the ways COVID-19 continues to impact cancer care and payment reform.
Dr. Andre Goy
October 25th 2020

Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies

Andre Goy, MD, chairman, director, and chief of the Division of Lymphoma at John Theurer Cancer Center in Hackensack, NJ, discussed the potential benefits of using CAR T-cell therapies as a second-line treatment.
Avalere Webinar on Oncology Care and Payment Reform
October 22nd 2020

Experts Discuss Oncology Care and Payment Reform in Avalere Webinar

Rose McNulty
Experts in cancer care and payment discussed the future of oncology care in a panel discussion hosted by Avalere Health on October 21, 2020.
Dr David Jackman on Dana Farber's Clinical Pathway Development Process
October 21st 2020

Dr David Jackman on Dana Farber's Clinical Pathway Development Process

At Dana Farber Cancer Institute, essential steps to developing clinical pathways include engaging physicians to buy-in, finding the optimal platform to store data, and displaying resulting content in a supportive and efficient way.
Lymphoma cell
October 16th 2020

Hodgkin Lymphoma Patients Face Noncancer Death Risk Despite Modern Therapies

Rose McNulty
A study and accompanying editorial from the Journal of Clinical Oncology found that Hodgkin lymphoma survivors still face a higher risk of non-cancer death than the general population.
Sara L. Douglas, PhD, RN, Case Western Reserve University
October 11th 2020

Dr Sara Douglas: Distance Caregivers of Patients With Cancer Have Distinct Needs

Distance caregivers have unique needs, explained Sara L. Douglas, PhD, RN, the Gertrude Perkins Oliva Professor in Oncology Nursing, associate dean for research, the Frances Payne Bolton School of Nursing, Case Western Reserve University.
Ibrance
October 10th 2020

Phase 2 Trial to Study Palbociclib in Early Stage Breast Cancer Based on ctDNA Monitoring

Rose McNulty
Natera’s Signatera ctDNA test will determine study eligibility and treatment effectiveness in HR-positive, HER2-negative breast cancer patients.
Dr Karen Winkfield on Improving Minority Access, Education for Precision Oncology
October 4th 2020

Dr Karen Winkfield on Improving Minority Access, Education for Precision Oncology

Addressing gaps in testing and education within precision oncology can assist in improving access to patients of color and other underserved populations.
Counties Experiencing Persistent Poverty Have Higher Cancer Mortality Rates
September 30th 2020

Counties Experiencing Persistent Poverty Have Higher Cancer Mortality Rates

Gianna Melillo
Throughout the United States, counties experiencing persistent poverty have disproportionately higher rates of cancer mortality, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.
Maura Abbott, PhD, AOCNP, CPNP, RN, Columbia University School of Nursing
September 29th 2020

Dr Maura Abbott Explains How Vaccine Form Determines Patient Contraindications

Form will determine in which patient populations, and why, a vaccine is not indicated for administration, said Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
September 28th 2020

Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions

Laura Joszt, MA
Speakers at Patient-Centered Oncology Care® highlighted injustices in the US health care system, the risk of financial toxicity, and how providers can do a better job to ensure their patients achieve health equity, during a panel discussion.
Dr Kashyap Patel Discusses COVID-19 Implications for PCOC® 2020
September 23rd 2020

Dr Kashyap Patel Discusses COVID-19 Implications for PCOC® 2020

The uncertainties precipitated by the coronavirus disease 2019 (COVID-19) pandemic around cancer care delivery are a challenging topic to be further addressed at this year’s Patient-Centered Oncology Care® 2020 virtual meeting.
How Oncology Practices Are Identifying, Addressing Health Needs Amid Pandemic
September 23rd 2020

How Oncology Practices Are Identifying, Addressing Health Needs Amid Pandemic

Through risk stratification and identifying social determinants of health, oncology practices are monitoring the direct and indirect effects of the pandemic, noted Jenifer Leaf Jaeger, MD, MPH, senior medical director of HealthEC.
Dr Joseph Alvarnas on Opportunities Presented by Virtual Format of PCOC® 2020
September 22nd 2020

Dr Joseph Alvarnas on Opportunities Presented by Virtual Format of PCOC® 2020

Through this year's virtual format for Patient-Centered Oncology Care® 2020, participants will be able to attend sessions, ask questions, and gain insight in an immediate, efficient way.
More Coffee, Longer Survival? Study Highlights Benefit in Metastatic Colon Cancer
September 19th 2020

More Coffee, Longer Survival? Study Highlights Benefit in Metastatic Colon Cancer

Allison Inserro
Patients with advanced colon cancer who drank 4 or more cups of coffee a day had 36% improved survival odds.
AACR Report Highlights Disparities in Cancer and the Need for Health Equity
September 18th 2020

AACR Report Highlights Disparities in Cancer and the Need for Health Equity

Laura Joszt, MA
Although innovations in cancer treatment have driven down overall cancer death rates and increased the number of survivors living with cancer, that progress has not benefitted everyone with cancer equally.
PCOC
September 9th 2020

Equity in Care Delivery Still at Top of PCOC 2020 Agenda, Amid “Undue Burden”

Mary Caffrey
Drs Joseph Alvarnas and Kashyap Patel, co-chairs of Patient-Centered Oncology Care® 2020, discuss what attendees can look forward to at the September 25 meeting.
IQVIA
September 7th 2020

Combatting COVID-19 With Real-World Evidence

Jennifer B. Christian, PharmD, MPH, PhD Matthew W. Reynolds, PhD
A vaccine isn’t the panacea many assume it will be. Even when it becomes available, the virus won’t go away. Real world evidence will be needed to guide decision making.
Picture of liver
September 5th 2020

Uptake of Palliative Care in Liver Cancer Needs Improvement, Report Says

Allison Inserro
Hepatocellular carcinoma is rising, and so is the need for increased awareness and use of palliative care, say the authors of a recent review.
Tafasitamab Plus Lenalidomide Added to NCCN Guidelines
August 28th 2020

Tafasitamab Plus Lenalidomide Added to NCCN Guidelines

AJMC Staff
NCCN added tafasitamab plus lenalidomide to their oncology practice guidelines for patients with relapsed or refractory DLBCL not otherwise specified.
Kashyap Patel, MD
August 25th 2020

When the Topic Is Dying: A Conversation With Kashyap Patel, MD

Mary Caffrey
Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care, associate editor of Evidence-Based Oncology, and vice president of the Community Oncology Alliance, discusses his new book.
Psychosocial Support for Patients With Cancer Waning as COVID-19 Pandemic Continues
August 24th 2020

Psychosocial Support for Patients With Cancer Waning as COVID-19 Pandemic Continues

Jaime Rosenberg
A recent survey showed the disruption in cancer care as a result of the pandemic is worrying professionals who provide psychosocial support to patients.
Mark Trushiem, MSc
August 16th 2020

Sidebar: CMS Seeks to Fix Medicaid Best-Price Barriers in Value-Based Contracting for High-Cost Therapies in Medicaid

Mary Caffrey
Proposed CMS rules would make it easier for state Medicaid programs to smooth the way for value-based contracts for high-cost gene therapies.
Amid Effort to Shrink Cancer Disparities, Authors Say COVID-19 Will Widen Them
August 13th 2020

Amid Effort to Shrink Cancer Disparities, Authors Say COVID-19 Will Widen Them

Mary Caffrey
As the American Society of Clinical Oncology calls for more aggressive efforts to bring equity to cancer care, authors in JAMA Oncology say COVID-19 is creating wider gaps.
Tafasitamab Combination Approved for Adults With R/R DLBCL
August 2nd 2020

Tafasitamab Combination Approved for Adults With R/R DLBCL

Mary Caffrey
A new treatment option is approved for patients with a common form of non-Hodgkin lymphoma who cannot have an autologous stem cell transplant.
Site Logo
July 21st 2020

American Oncology Network, LLC Announces New Advisory Board Chair and Executive Committee

The American Oncology Network, LLC, has added 5 medical oncologists to its Executive Committee.
Site Logo
July 20th 2020

Access to Care: Burris Says United With Our Patients, We Accelerate Progress Together

Maggie L. Shaw
“We’ve had advancements, but we need to go faster,” said ASCO President Howard A. "Skip" Burris III, MD, as he stressed the importance of advancing therapies for better patient outcomes by addressing obstacles to patients’ care. “Access to care, access to clinical trials, and access to information are really key.”
Site Logo
July 14th 2020

Florida Cancer Specialists Names New CEO

Nathan H. Walcker will succeed Brad Prechtl on August 1, 2020.
Don't Delay Cancer Care During COVID-19 Crisis
July 1st 2020

Don't Delay Cancer Care During COVID-19 Crisis

Amy McNally, MD
Federal and state officials have implemented policies and safeguards to slow transmission of the virus. Most troubling were state moratoriums on “elective” surgical procedures.
Site Logo
June 19th 2020

From the Editor-in-Chief: Bigger Questions of Systems, Viruses, and the Lives of Real People

Joseph Alvarnas, MD
As I recall the early days of the HIV/AIDS pandemic, what stands out most is its profound human cost and the courage of those who helped our society transcend it. We are in the midst of a time in which the human toll of COVID-19 and the enormity of the path ahead are clear.
<1
...
202122232425262728
...
188>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo